Baidu
map

J Cell Sci:熊文勇研究组在胰岛素抵抗调控GLUT4分布模式的研究中取得重要进展

2017-04-29 佚名 昆明植物研究所

葡萄糖转运体(GLUT4)是脂肪细胞和肌细胞中最主要的葡萄糖转运蛋白,胰岛素调控的GLUT4膜转运对于机体血糖平衡的维持至关重要。GLUT4转运障碍是机体产生胰岛素抵抗或患有2型糖尿病的主要表现之一。目前,绝大多数有关GLUT4的研究主要针对GLUT4的表达和膜转运,关于GLUT4自身蛋白活性的研究也有少量报道。然而对于GLUT4在其行使葡萄糖转运功能的地方——细胞膜上的分布模式及其相关影响因素的

葡萄糖转运体(GLUT4)是脂肪细胞和肌细胞中最主要的葡萄糖转运蛋白,胰岛素调控的GLUT4膜转运对于机体血糖平衡的维持至关重要。GLUT4转运障碍是机体产生胰岛素抵抗或患有2型糖尿病的主要表现之一。目前,绝大多数有关GLUT4的研究主要针对GLUT4的表达和膜转运,关于GLUT4自身蛋白活性的研究也有少量报道。然而对于GLUT4在其行使葡萄糖转运功能的地方——细胞膜上的分布模式及其相关影响因素的研究却极少。另外,由于衍射极限的存在使得传统光学显微镜的成像分辨率无法突破200 nm, 这也使得研究者们无法在超高分辨率甚至单分子水平去获取GLUT4在细胞膜上的分布模式的详细信息。

随着超分辨成像技术的出现及迅速发展,使得成像分辨率最高可达到20nm以下,这为科研人员提供了绝佳的工具和手段,从而能在单分子水平去研究细胞膜上GLUT4的分布模式。

中国科学院昆明植物研究所熊文勇研究组与长春应用化学研究所电分析国家重点实验室王宏达研究组合作,利用直接随机光学重建超分辨显微镜(dSTORM),对不同生理状态下脂肪细胞质膜上GLUT4的分布模式进行观察和统计分析,从单分子水平解析了脂肪细胞质膜表面GLUT4在不同生理状态下的分布模式变化。结果显示在胰岛素刺激后,细胞质膜上的GLUT4除了在数量上明显增加外,蛋白成簇能力和参与成簇的蛋白比例的明显下降,趋向于形成小簇或更加随机、弥散的分布模式;当细胞产生胰岛素抵抗后,细胞对胰岛素的敏感性降低,然而相对于正常细胞,胰岛素抵抗让细胞质膜表面的GLUT4呈现出更趋向于成簇或形成较大的簇的分布模式状态。此外,通过突变GLUT4蛋白N端F5QQI序列,破坏脂筏以及微丝等手段初步探究了细胞质膜上GLUT4分布模式的影响因素,发现F5QQI序列和脂筏都与质膜上GLUT4的分布模式密切相关。这是首次发现胰岛素抵抗会导致细胞膜上的GLUT4的分布模式变得更加聚集,这个发现使人们从一个全新的角度对胰岛素抵抗有了更深刻的认识,也为进一步研究肥胖或糖尿病发病机制提供了新的理论基础。

本研究已在线发表于“Journal of Cell Science”杂志。该研究得到了中科院百人计划(292013312D11004)、国家自然科学基金(81270919)及云南省基金(39Y33H521261)的支持。

原始出处:

Lan Gao, Junling Chen, Jing Gao,et al.Super-resolution microscopy reveals the reorganization of GLUT4 on plasma membrane regulated by insulin resistance.J Cell Sci 2016 : doi: 10.1242/jcs.192450

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2026376, encodeId=0b0d20263e64d, content=<a href='/topic/show?id=4c02960e649' target=_blank style='color:#2F92EE;'>#重要进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96076, encryptionId=4c02960e649, topicName=重要进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Jul 18 00:50:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869932, encodeId=661b18699320d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 17:50:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749718, encodeId=5b171e497185c, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Mar 21 12:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960191, encodeId=1e7519601915d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 03 23:50:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022087, encodeId=c095202208e89, content=<a href='/topic/show?id=7f4231e2731' target=_blank style='color:#2F92EE;'>#分布模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31727, encryptionId=7f4231e2731, topicName=分布模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Fri May 19 12:50:00 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2026376, encodeId=0b0d20263e64d, content=<a href='/topic/show?id=4c02960e649' target=_blank style='color:#2F92EE;'>#重要进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96076, encryptionId=4c02960e649, topicName=重要进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Jul 18 00:50:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869932, encodeId=661b18699320d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 17:50:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749718, encodeId=5b171e497185c, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Mar 21 12:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960191, encodeId=1e7519601915d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 03 23:50:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022087, encodeId=c095202208e89, content=<a href='/topic/show?id=7f4231e2731' target=_blank style='color:#2F92EE;'>#分布模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31727, encryptionId=7f4231e2731, topicName=分布模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Fri May 19 12:50:00 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2026376, encodeId=0b0d20263e64d, content=<a href='/topic/show?id=4c02960e649' target=_blank style='color:#2F92EE;'>#重要进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96076, encryptionId=4c02960e649, topicName=重要进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Jul 18 00:50:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869932, encodeId=661b18699320d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 17:50:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749718, encodeId=5b171e497185c, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Mar 21 12:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960191, encodeId=1e7519601915d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 03 23:50:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022087, encodeId=c095202208e89, content=<a href='/topic/show?id=7f4231e2731' target=_blank style='color:#2F92EE;'>#分布模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31727, encryptionId=7f4231e2731, topicName=分布模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Fri May 19 12:50:00 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2018-03-21 baoya
  4. [GetPortalCommentsPageByObjectIdResponse(id=2026376, encodeId=0b0d20263e64d, content=<a href='/topic/show?id=4c02960e649' target=_blank style='color:#2F92EE;'>#重要进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96076, encryptionId=4c02960e649, topicName=重要进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Jul 18 00:50:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869932, encodeId=661b18699320d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 17:50:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749718, encodeId=5b171e497185c, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Mar 21 12:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960191, encodeId=1e7519601915d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 03 23:50:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022087, encodeId=c095202208e89, content=<a href='/topic/show?id=7f4231e2731' target=_blank style='color:#2F92EE;'>#分布模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31727, encryptionId=7f4231e2731, topicName=分布模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Fri May 19 12:50:00 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2017-05-03 维他命
  5. [GetPortalCommentsPageByObjectIdResponse(id=2026376, encodeId=0b0d20263e64d, content=<a href='/topic/show?id=4c02960e649' target=_blank style='color:#2F92EE;'>#重要进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96076, encryptionId=4c02960e649, topicName=重要进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Jul 18 00:50:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869932, encodeId=661b18699320d, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 17:50:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749718, encodeId=5b171e497185c, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Mar 21 12:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1960191, encodeId=1e7519601915d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 03 23:50:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022087, encodeId=c095202208e89, content=<a href='/topic/show?id=7f4231e2731' target=_blank style='color:#2F92EE;'>#分布模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31727, encryptionId=7f4231e2731, topicName=分布模式)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Fri May 19 12:50:00 CST 2017, time=2017-05-19, status=1, ipAttribution=)]

相关资讯

CELL METAB:调节血糖的神奇微生物-益生素(post-biotics)

【益生素(post-biotics)可帮助肥胖者避免糖尿病】你可能听说过益生元和益生菌,现在你将更多听到的是益生素(post-biotics)。注:post-biotics还未有正式译名,暂叫益生素,也有的称其为活生素。麦克马斯特大学的研究人员开始确认益生素(post-biotics),一种细菌副产物,如何降低血糖,并调节胰岛素更好的工作。生物化学和生物医学助理教授,Jonathan Schert

Nat Biomed Eng:叶海峰研究组发表治疗胰岛素抵抗智能传感器的重要研究成果

近期,国际知名学术期刊《自然-生物医学工程》(Nature Biomedical Engineering)在线发表了来自华东师范大学、瑞士苏黎世联邦理工大学等多家单位合作的题为“Self-adjusting synthetic gene circuit for correcting insulin resistance”最新研究成果。该项研究主要是利用合成生物学策略设计、构建了一种智能胰岛素传感器

Diabetes:山东大学龚瑶琴课题组在肥胖和胰岛素领域获新进展

近日,《Diabetes》杂志(IF = 8.784)发表了山东大学基础医学院遗传学系龚瑶琴教授课题组题为“Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity”的论文,论文揭示了CUL4B蛋白在肥胖和胰岛素抵抗发生中的重要作用。本项研究由遗传学系青年

利用尿液代谢产物来预测个体患糖尿病的风险

图片摘自:en.wikipedia.org 2017年4月6日 讯 /生物谷BIOON/ --近日,在美国奥兰多举办的第99届内分泌学会会议上,来自杜克大学医学院的研究人员表示,他们在患糖尿病、肥胖的黑人青少年机体的尿液中发现了一种特殊的代谢标记物,这种新型标记物或有望帮助研究人员与有效预测青少年患2型糖尿病的风险。 医学博士Pinar Gumus Balikcioglu表示,在进行

NEW ENGL J MED:两篇研究揭示:糖尿病患者数量上升的根源!

【糖尿病继续不断上升】两项关于糖尿病的新研究提供了好消息,但总体来说,血糖仍然是公共卫生负担的重中之重。第一项研究研究了美国儿童1型和2型糖尿病的发病情况,发现了这一令人不安的趋势:从2002年到2012年,两种糖尿病的发病率都有所上升,特别是种族和少数民族。但在第二项研究中提出了一点希望:瑞典研究人员报告说:“两种类型的糖尿病患者心脏病和中风的发生率都有所下降”。美国糖尿病协会首席科学,医学和任

Baidu
map
Baidu
map
Baidu
map